Blue-Emu Maximum Pain Relief

openFDA label record#

This page contains supplementary openFDA label data. For the canonical label presentation, use the corresponding DailyMed Structured Product Label.

Verified complete openFDA source JSON (canonical bytes are SHA-256 checked before publication)

Brand name
Blue-Emu Maximum Pain Relief
Generic name
TROLAMINE SALICYLATE
Manufacturer
Kingsway Pharmaceuticals dba NFI, LLC
Product type
HUMAN OTC DRUG
SPL set ID
c863351a-951b-4f7c-a9c0-4289d702054a
SPL ID
5dcb097a-a4ed-4d5e-93c4-86164fa0799f
Version
4
Effective date
2025-09-09
Source export date
2026-09-28
Source partition
7
Source file
https://download.open.fda.gov/drug/label/drug-label-0007-of-0014.json.zip
Source object key
raw/openfda/drug-label/2026-09-28/bb1af06e95bcf9567b07e56fcf3a03c0cac3c7c82ff89d4c970881174949e5b7/drug-label-0007-of-0014.json.zip
Source manifest SHA-256
cd2e66336a5cd2223fa3995098fdbdb84c6a7ee5c0a4addb236ccb22dd1e6887
Import run
20260929T050834Z
Imported at
2026-09-29 05:46:05
Harmonized routes table
Harmonized routes
TOPICAL

Warnings cross-check#

openFDA text is shown for search and cross-checking; DailyMed SPL is canonical.

Warnings sections page 1 of 1 · 2 matching rows.

warnings

Warnings For external use only Allergy alert: If prone to allergic reaction from aspirin or salicylates, consult a doctor before use. When using this product • use only as directed • do not bandage tightly or use with a heating pad • avoid contact with eyes or mucous membranes • do not apply to wounds or damaged skin. Stop use and ask a doctor if • condition worsens • symptoms persist for more than 7 days or clear up and occur again within a few days • redness is present • irritation develops. If pregnant or breast-feeding, ask a health professional before use. Keep out of reach of children. If swallowed, get medical help or contact a Poison Control Center right away.

warnings and cautions

Ca Consumer Warning: This product can expose you to trace levels of diethanolamine (DEA), which is know to the State of California to cause cancer. For more information go to www.P65Warnings.ca.gov

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.